Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14961407 | 0.98 | MEN1 (0.36) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL14961338 | 0.95 | MEN1 (0.38) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL8573955 | 0.95 | MEN1 (0.33) | MEN1KMT2AKDM4CL3MBTL1 | |
| SCHEMBL14961410 | 0.94 | MEN1 (0.32) | MEN1KMT2AKDM4CL3MBTL1 | |
| SCHEMBL14961370 | 0.91 | MEN1 (0.41) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL14961365 | 0.91 | MEN1 (0.41) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL14961341 | 0.90 | MEN1 (0.33) | MEN1KMT2AKDM4CL3MBTL1 | |
| SCHEMBL14961384 | 0.89 | MEN1 (0.43) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL14961367 | 0.89 | MEN1 (0.43) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL14961385 | 0.89 | MEN1 (0.43) | MEN1KMT2AKDM4CL3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130130102-A1 | ETHER COMPOUND, ELECTROLYTE COMPOSITION FOR NON-AQUEOUS BATTERY, BINDER COMPOSITION FOR NON-AQUEOUS BATTERY ELECTRODE, SLURRY COMPOSITION FOR NON-AQUEOUS BATTERY ELECTRODE, ELECTRODE FOR NON-AQUEOUS BATTERY AND NON-AQUEOUS BATTERY | ZEON CORPORATION (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20130130102-A1 | ETHER COMPOUND, ELECTROLYTE COMPOSITION FOR NON-AQUEOUS BATTERY, BINDER COMPOSITION FOR NON-AQUEOUS BATTERY ELECTRODE, SLURRY COMPOSITION FOR NON-AQUEOUS BATTERY ELECTRODE, ELECTRODE FOR NON-AQUEOUS BATTERY AND NON-AQUEOUS BATTERY | ZEON CORPORATION (JP) | 2013-05-23 | — | — | US | disclosed |
| US-5744678-A | NICKEL COMPOUND, ORGANOPHOSPHORUS COMPOUND, ORGANOALUMINUM COMPOUND, CARBON-HALOGEN COMPOUNDS; CATALYST SELECTIVITY | NIPPON OIL CO., LTD. (JP) | 1998-04-28 | — | — | US | disclosed |
| US-5728641-A | Catalyst component for the polymerization of olefins | NIPPON OIL COMPANY, LIMITED (JP) | 1998-03-17 | — | — | US | disclosed |
| EP-0758563-A1 | OLEFIN OLIGOMERIZATION CATALYST AND PROCESS FOR THE PREPARATION OF OLEFIN OLIGOMER USING IT | NIPPON OIL COMPANY, LTD. (JP) | 1997-02-19 | — | — | EP | disclosed |
| EP-0587440-A2 | Catalyst component for the polymerisation of olefins and process for preparing olefin polymers using same | NIPPON OIL COMPANY, LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130130102-A1 | ETHER COMPOUND, ELECTROLYTE COMPOSITION FOR NON-AQUEOUS BATTERY, BINDER COMPOSITION FOR NON-AQUEOUS BATTERY ELECTRODE, SLURRY COMPOSITION FOR NON-AQUEOUS BATTERY ELECTRODE, ELECTRODE FOR NON-AQUEOUS BATTERY AND NON-AQUEOUS BATTERY | NONO, VDAC1, SCO2 | MEN1 2534/4885KMT2A 1165/4885KDM4C 558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.